SPEAKERS
Chi Van Dang
AFFILIATION:
Ludwig Institute for Cancer Research, New York, NY
POSITION TITLE:
Scientific Director and Professor
EDUCATION/TRAINING:
University of Michigan, Ann Arbor, MO B.S. 05/1975 Chemistry
Georgetown University, Washington D.C. Ph.D. 05/1978 Chemistry
Johns Hopkins University, Baltimore, MD M.D. 06/1982 Medicine
HONORS:
2021 George Klein Lecture & Medal, Karolinska Institute, Stockholm, Sweden
2020 Cartwright Memorial Lectureship, University for Utah, Salt Lake City
2018 Fellow of the American Association for Cancer Research Academy
2017 Heath Memorial Award, The University of Texas MD Anderson Cancer Center
2014 Peter A. Steck Memorial Award Lectureship, The University of Texas MD Anderson Cancer Center
2013 Drexel Cancer Biology Lectureship, Drexel Molecular Medicine Symposium
2012 The Huntsman Cancer Institute Susan Cooper Jones Memorial Lectureship
2012 Johns Hopkins University Distinguished Alumnus Award for Scientific Achievement
2011 Fellow of the American Academy of Arts and Sciences
2011 The Tsung Hsien and Shu Yung Wu Award Lectureship in Cancer Research, University of Michigan
2006 National Academy of Medicine (Institute of Medicine, the National Academies) elected 2006
2005 Vietnamese-American National Gala Golden Torch Award (Medicine/Education)
2004 The Johns Hopkins Family Professorship in Oncology Research
2003 Distinguished Mark Brothers Award, Indiana Univ SOM
2002-2003 American Society for Clinical Investigation, President
1999-2007 NCI/NIH Merit Award
1997 Association of American Physicians
1997 LSA Stohlman Scholar Award
1993 American Society for Clinical Investigation
1992-1997 Leukemia Society of America Scholar Award
1989 Henry M. and Lillian Stratton Foundation Award
1989 American Cancer Society Junior Faculty Award
1987 Phi Beta Kappa; American Cancer Society Senior Fellow (California Chapter)
1983 Phi Lambda Upsilon; Zorbach Award for Ph.D. dissertation; Alpha Omega Alpha; Schwentker Award (J. Hopkins housestaff)
RESEARCH INTERESTS:
I am the Scientific Director of the Ludwig Institute for Cancer Research and an established basic and translational researcher, with 29 years of experience doing cancer biology research at Johns Hopkins and now continuing that work as a professor at The Wistar Institute. My laboratory made the seminal connection between the MYC oncogene and cancer metabolism and has continued to contribute to the understanding of how MYC, hypoxia, and alterations in cancer immuno-metabolism contribute to cancer development and how they can be exploited for therapeutic benefit. More recently, we documented that oncogenic MYC disrupts the circadian clock, thereby linking diurnal oscillation of maintenance metabolism to its disruption by MYC to induce proliferative metabolism and accumulation of biomass.
Ongoing and recently completed projects that I would like to highlight include:
5 R01 CA057341-28
Dang (PI)
02/11/2017-01/31/2022
NIH/NCI
c-Myc Targets in the Pathogenesis of Human Cancers
R01 HG009518
Ji (PI, Johns Hopkins), Role: Co-Investigator
08/10/2018-05/31/2022
NHGRI Big Data Methods for Decoding Gene Regulation
R01 CA252225-01A1
Dang and Stanger (PIs)
05/03/2021-04/30/2025
NIH/NCI
Defining Metabolic Adaptations within the PDAC "arid" Tumor Microenvironment
R01 CA051497-29
Dang (PI)
12/02/2020-11/30/2025
NIH/NCI
Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis
PUBLICATIONS:
Complete List of Published Work in MyBibliography:
https://www.ncbi.nlm.nih.gov/pubmed/?term=dang+cv